BFA
ARRY

BlackRock Fund Advisors’s Array Biopharma Inc ARRY Stock Holding History

BlackRock Fund Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$65.8M Buy
7,483,416
+1,860,265
+33% +$13.7M 0.01% 1498
2016
Q3 		$38M Buy
5,623,151
+375,851
+7% +$1.45M 0.01% 1756
2016
Q2 		$18.7M Buy
5,247,300
+47,621
+0.9% +$155K ﹤0.01% 2062
2016
Q1 		$15.3M Buy
5,199,679
+99,340
+2% +$298K ﹤0.01% 2123
2015
Q4 		$21.5M Sell
5,100,339
-245,872
-5% -$1.12M 0.01% 2000
2015
Q3 		$24.4M Buy
5,346,211
+176,730
+3% +$1.05M 0.01% 1868
2015
Q2 		$37.3M Sell
5,169,481
-465,816
-8% -$3.44M 0.01% 1720
2015
Q1 		$41.5M Buy
5,635,297
+555,868
+11% +$3.96M 0.01% 1633
2014
Q4 		$24M Buy
5,079,429
+433,163
+9% +$1.71M 0.01% 1947
2014
Q3 		$16.6M Sell
4,646,266
-259
-0% -$1.02K ﹤0.01% 2069
2014
Q2 		$21.2M Sell
4,646,525
-346,563
-7% -$1.43M 0.01% 1986
2014
Q1 		$23.5M Buy
4,993,088
+229,545
+5% +$1.15M 0.01% 1908
2013
Q4 		$23.9M Buy
4,763,543
+187,430
+4% +$1.02M 0.01% 1894
2013
Q3 		$28.5M Buy
4,576,113
+582,533
+15% +$3.46M 0.01% 1729
2013
Q2 		$18.1M Buy
+3,993,580
New +$21.5M 0.01% 1915

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock Fund Advisors's ARRY Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Array Biopharma Inc (ARRY) stake by 33% in Q4 2016, buying an estimated $13.7M and bringing the position to 7,483,416 shares worth $65.8M. The position accounts for 0.01% of the portfolio, ranked #1498.

BlackRock Fund Advisors first reported a position in ARRY in Q2 2013 and has held it in 15 quarters since. 167 funds tracked by Wall St. Rank hold ARRY as of Q4 2016.

  • BlackRock Fund Advisors held 7,483,416 shares of Array Biopharma Inc worth $65.8M as of Q4 2016.
  • BlackRock Fund Advisors bought 1,860,265 Array Biopharma Inc shares in Q4 2016, an estimated $13.7M.
  • Array Biopharma Inc made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1498 holding.
  • BlackRock Fund Advisors first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 15 quarters since.
  • 167 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.